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Abstract
Background:  Failure to be comprehensive can distort the results of a systematic review.
Conversely, extensive searches may yield unmanageable number of citations of which only few may
be relevant. Knowledge of usefulness of each source of information may help to tailor search
strategies in systematic reviews.
Methods: We conducted a systematic review of prevalence/incidence of maternal mortality and
morbidities from 1997 to 2002. The search strategy included electronic databases, hand searching,
screening of reference lists, congress abstract books, contacting experts active in the field and web
sites from less developed countries. We evaluated the effectiveness of each source of data and
discuss limitations and implications for future research on this topic.
Results: Electronic databases identified 64098 different citations of which 2093 were included.
Additionally 487 citations were included from other sources. MEDLINE had the highest yield
identifying about 62% of the included citations. BIOSIS was the most precise with 13.2% of screened
citations included. Considering electronic citations alone (2093), almost 20% were identified
uniquely by MEDLINE (400), 7.4% uniquely by EMBASE (154), and 5.6% uniquely by LILACS (117).
About 60% of the electronic citations included were identified by two or more databases.
Conclusions: This analysis confirms the need for extending the search to other sources beyond
well-known electronic databases in systematic reviews of maternal mortality and morbidity
prevalence/incidence. These include regional databases such as LILACS and other topic specific
sources such as hand searching of relevant journals not indexed in electronic databases. Guidelines
for search strategies for prevalence/incidence studies need to be developed.
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Background
The importance of comprehensive search strategies to
identify 'all relevant articles' when conducting systematic
reviews has been long documented [1]. Comprehensive
strategies include systematic searching of multiple data-
bases as well as hand searching and contacting relevant
experts. These strategies, however, may yield thousands of
citations from which only a small number is eventually
included in the review. Knowing which sources yield a
reasonable number of relevant studies on a health topic
may help those planning and conducting systematic
reviews in that particular area.
At the World Health Organization (WHO), we have con-
ducted a systematic review of prevalence/incidence of
maternal mortality and morbidities from 1997 to 2002.
The primary objective of this review is to assist in mapping
the burden of reproductive ill-health by providing a com-
prehensive, standardized and reliable tabulation of data
on the prevalence/incidence of maternal morbidity and
mortality [2]. This article evaluates the usefulness of dif-
ferent sources in identifying data for the systematic
review. We also discuss limitations of the databases and
implications for future systematic reviews of observa-
tional studies.
Methods
The methodology of the systematic review and the search
strategy have been described elsewhere [3]. In brief, we
searched for reports of maternal mortality and morbidity
across various study designs (cross-sectional, cohort, cen-
sus, RCTs, etc.). The search included multiple electronic
databases: MEDLINE, Popline, EMBASE, CINAHL, CAB
Abstracts, Econlit, Sociofile, LILACS, BIOSIS and PAIS
International. Specialist librarians together with the
reviewers developed database-specific search strategies
according to the particular subject headings and searching
structure of the databases (See Additional file 1). Given
the importance of retrieving data from developing coun-
tries, we also identified and searched databases in devel-
oping countries such as Index Medicus of the Eastern
Mediterranean Region (IMEMR) [4]; African Index Medi-
cus (AIM) [5]; IndMED [6], a bibliographic database of
Indian biomedical journals; and HELLIS.ORG [7], a net-
work of health science libraries across Asia. However, the
search for some of these databases did not yield complete
results due to limited functionality of these systems (e.g.
lack of essential information from the citation, inconsist-
encies) and their results, except for IMEMR, are not pre-
sented independently but under 'other' in Table 1. The
search also included hand searching of journals not
indexed in major databases and available at WHO's
library, government reports, screening of reference lists of
retrieved articles, congress abstract books, and contacting
experts active in the field for unpublished datasets.
We downloaded all citations identified by electronic data-
bases into Reference Manager®  software. Selection of
eligible studies involved two stages; the first stage con-
sisted of screening of title and/or abstracts from the cita-
tions downloaded. Citations were excluded if any of the
following applied: (i) data collection dates were not
Table 1: Results of the various types of searches
Source Number identified Number included Number unique 
included*
Sensitivity (%) Precision (%)
MEDLINE 38986 1590 400 61.6 4.1
Popline 3255 297 91 11.5 9.1
EMBASE 23133 1135 154 43.9 4.9
CINAHL 9090 263 9 10.2 2.9
CAB Abstracts 4317 190 19 7.4 4.4
Econlit 188 4 1 0.2 2.1
SocioFile 1618 32 8 1.2 2.0
LILACS 1456 137 117 5.3 9.4
BIOSIS 3313 436 21 16.9 13.2
PAIS International 705 21 3 0.8 3.0
IMEMR 109 11 5 0.4 10.1
All Electronic 
databases**
64098 2093 NA 81.1 3.3
Other§ 487 487 487 18.9 NA
TOTAL± 64585 2580 2580 NA 4.0
* Refers to the number of citations that were exclusively identified by each database.
** Refers to all citations identified through the electronic databases above after duplicate entries are removed.
§ Includes hand searching, contacting experts, conference proceedings, reference lists, library collections of journals, and databases in developing 
countries.
± Refers to all citations identified through all methods after duplicate entries are removed. NA: Non-applicableBMC Medical Research Methodology 2005, 5:6 http://www.biomedcentral.com/1471-2288/5/6
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reported, (ii) data were collected only before 1990, (iii)
part of the data were collected before 1980 and disaggre-
gation by year was not possible (in order to exclude data
before 1990), (iv) number of study participants was less
than 200, (v) the study design was case-control and inci-
dence/prevalence estimates from the defined population
cannot be calculated, (vi) the methodology was not
described. The second stage consisted of full-text evalua-
tion of those citations that were not excluded in the first
step applying the same criteria. For practical reasons, stud-
ies identified by other sources were only entered in Refer-
ence Manager® if they were eventually included in the
review.
We recorded the source or sources of each citation. For
each source, we calculated number of citations identified,
included, and number included that were unique to the
source. The sensitivity of each source was defined as the
number of included citations identified by the source over
the total number included. The precision was defined as
the number of included citations identified by a source
over the number of both included and excluded citations
identified by that source. This review had no language
restrictions and we recorded the language in which the
report was written. Detailed results regarding languages
will be reported separately.
Two reviewers performed the screening for all citations. In
order to estimate the level of disagreement between the
two reviewers within 2.5% of the true value, they inde-
pendently screened title/abstracts for a sample of citations
(560). This sample size assumes a 95% confidence inter-
val and that the level of disagreement between the two
reviewers will not exceed 10% [8]. The percentage of
agreement was 88.9% (95% CI 86.0% to 91.4%). The
inter-observer agreement beyond chance was calculated
using the Kappa statistics and found to be 0.60 (95% CI
0.52 to 0.69). This value corresponds to moderate to sub-
stantial agreement between the reviewers.
Results
For the time period from 1997 to 2002, 64098 different
citations from electronic databases were identified of
which 2093 were included. Additionally, 487 citations
were included from other sources. There were 92 citations
for which we could not obtain full text and, therefore, they
could not be assessed (2% of those that required full-text
evaluation).
Table 1 shows a breakdown of the results by source
including, for each source of data, number of citations
identified, number included, number included unique to
each source, sensitivity and precision. Overall, electronic
databases identified four fifths (81.1%) of the included
citations. MEDLINE and EMBASE which identified about
62% and 44% of the included citations respectively were
most sensitive. Considering electronic citations alone
(2093), almost 20% were identified uniquely by
MEDLINE (400), 7.4% uniquely by EMBASE (154), and
5.6% uniquely by LILACS (117). About 60% of the elec-
tronic citations included were identified by 2 or more
databases.
Overall, in terms of precision, we included 1 in 25
screened citations (4%). The most precise database was
BIOSIS where 13.2% of the screened citations were
included; IMEMR, LILACS and Popline followed this with
10.1%, 9.4% and 9.1%, respectively (see Table 1).
MEDLINE and EMBASE were similarly precise, 4.1% and
4.9%, respectively.
Preliminary analysis regarding languages revealed that
about 20% of the included studies were published in
other languages than English. Spanish and French were,
after English, the most used languages for reporting.
Discussion
Failure to identify relevant information in systematic
reviews can result in bias [9]. The importance of including
other sources of data in addition to electronic databases in
general and MEDLINE in particular has been docu-
mented, especially for clinical or randomised controlled
trials [1,9-11]. On the other hand, search strategies for sys-
tematic reviews of observational data on morbidities are
less precise, more difficult to narrow the focus and have
been studied to a lesser extent [12]. This led us to perform
for our systematic review an extensive search strategy that
is highly sensitive but barely precise. From 64098 cita-
tions identified only 2580 were included which represents
4% of the scrutinized articles.
Although MEDLINE identified about 62% of all citations
and 76% of electronic citations relevant for this review,
sources of data other than the major electronic databases
are confirmed to be crucial. Some 487 (one fifth) citations
were identified by reference lists of articles, expert con-
tacts, congress proceedings, abstract books, hand search-
ing of journals available in libraries that are not indexed
in electronic databases, and other emerging databases in
developing countries. As expected, there has been a large
overlap between databases: 60% were identified by two or
more databases and about 44% were identified by
MEDLINE and EMBASE together. These two databases
also provided the largest number of unique citations and
both are considered necessary. PAIS International and
Econlit only identified 3 and 1 citations, respectively, that
were not identified by any other database and they could
probably be disregarded in future reviews.BMC Medical Research Methodology 2005, 5:6 http://www.biomedcentral.com/1471-2288/5/6
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The nature of this systematic review with its focus on set-
tings where burden of disease is highest necessitates exten-
sive searching of developing country sources. However,
literature from developing countries is difficult to access
and it is not well represented in MEDLINE or other well-
known electronic databases [13,14]. An editorial by
Zielinksi in 1995 stated that only 2% of the journals
indexed in MEDLINE or the Science Citation Index were
from developing countries [15]. In 2004, the situation
was similar. We calculated the number of journals pub-
lished in developing countries and also indexed in
MEDLINE to be about 6%. In 1996, the whole Latin
American continent accounted for 0.39% of the total
number of articles included in MEDLINE, down from a
high of 2.03% in 1966 [16]. One of the reasons for this is
the indexing of journals on a priority system where the
impact factor of a journal influences its chances of being
indexed. This results in country bias since western jour-
nals have in general higher impact factors, and they are
therefore more likely to be indexed than those from devel-
oping countries.
The value of LILACS database to improve the quality of
systematic reviews has been previously reported [17]. Our
analysis confirms LILACS as a unique source of informa-
tion for the Latin America and the Caribbean region that
is not covered in other databases (117 unique citations
included). Unfortunately, specific databases for other less
developed regions like Asia and Africa, are just emerging
or their access and functioning limited (e.g. AIM, IMEMR,
IndMED, HELLIS.ORG). Although these regional data-
bases are included in the review, the results are not pre-
sented individually but under 'other' in Table 1. With
these databases, we experienced language barriers, diffi-
culty in obtaining abstracts and full-text reports, inconsist-
encies, lack of essential information from the citation (e.g.
year or title missing) and other technical problems. We
believe that the low number of citations identified by
IMEMR (see Table 1) is due more to the limitations men-
tioned above than to lack of data. These regional data-
bases provide unique relevant citations and incomplete
access limits their usefulness. Strengthening the function-
ality and improving the search facility of these databases
could provide substantial relevant information.
A limiting factor for identifying citations is related to late
indexing of journals in electronic databases. Search strate-
gies for this review were conducted in early 2003 to iden-
tify articles published in 2002 or earlier. While only few
articles published in 2002 could be expected not to be in
the databases by 2003, some articles published in 1997
were only appearing in the databases as late as 2003. Tra-
ditionally, EMBASE has been found to index faster than
MEDLINE, thus supporting the argument to search multi-
ple databases [18]. Furthermore, each database producer
has a particular schedule that the searcher needs to be
aware of. For example, MEDLINE available through
OVID, due to the updating of the MeSH terms by the
National Library of Medicine, will cease entry of new cita-
tions in November and only update the database in Janu-
ary of the following year. These factors need to be
considered in assessing the yield from different databases.
It is necessary to determine how to capture these 'late
indexed' citations whether by delaying the running of the
search or building into follow-up studies the need to cap-
ture these citations. The electronic search for this review
would have probably captured more citations had it been
run in 2004.
This systematic review involved significant financial and
human resources over a 3-year period [3]. Screening of a
large number of citations and retrieving the full text of
about 5000 articles have resource implications that need
to be balanced with the benefits of the results. For this
type of reviews, decisions on the extent of the comprehen-
siveness of the search strategy should take the resource
implications into account. A careful selection of databases
to be used and tailored search strategies for each database
would help to maximise the benefits compared to costs.
Conclusions
1. In contrast with RCTs, guidelines for search strategy of
systematic reviews of observational studies in general, and
incidence/prevalence studies in particular, need to be
developed.
2. Searching beyond the major electronic databases such
as MEDLINE or EMBASE is necessary to identify studies in
journals from less developed countries.
3. Regional databases indexing citations from local jour-
nals not reaching MEDLINE are especially relevant for this
type of systematic review. They need to be fully function-
ing and made worldwide accessible. A network for access-
ing the full text of these articles would be helpful.
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